# Gilead Sciences, Inc. - Inspection Records

Source: https://www.keypedia.com/companies/gilead-sciences-inc/05c4ed0b-5c05-4c0e-996e-9e344fef905c

> Inspection records and compliance data for Gilead Sciences, Inc. in Foster City, California. Access full analysis and detailed observations.

---

## Details

- Name: Gilead Sciences, Inc.
- FEI Number: 1000523075
- City: Foster City
- State: California
- Country Name: United States
- Address Line 1: 333 Lakeside Dr
- Zip Code: 94404
- Facility Type: Manufacturer

## Related Documents

- [483 - Gilead Sciences, Inc. - Unknown Date](https://www.keypedia.com/records/483/gilead-sciences-inc/b48d7486-8192-41f4-8c73-b357f29d663d) — source: FDA, date: Invalid Date
- [CRL - Gilead Sciences, Inc. - Unknown Date](https://www.keypedia.com/records/crl/gilead-sciences-inc/72a781e8-af07-40d3-9619-cd73a63e56d8) — source: FDA, date: Invalid Date
- [FDA Inspection 1300496 - Gilead Sciences, Inc. - 2026-01-16](https://www.keypedia.com/records/fda_inspections/gilead-sciences-inc/5929295f-e25e-484f-9dc1-296b80be96f0) — source: FDA, date: January 16, 2026
- [FDA Inspection 1300496 - Gilead Sciences, Inc. - 2026-01-16](https://www.keypedia.com/records/fda_inspections/gilead-sciences-inc/d3db75e6-f2e4-4076-bd64-7e5ef2fd86dd) — classification: No Action Indicated (NAI), source: FDA, date: January 16, 2026
- [FDA Inspection 1258330 - Gilead Sciences, Inc. - 2025-01-29](https://www.keypedia.com/records/fda_inspections/gilead-sciences-inc/fe311bf5-631b-4491-9c5e-f31838502b8f) — source: FDA, date: January 29, 2025
- [FDA Inspection 1258330 - Gilead Sciences, Inc. - 2025-01-29](https://www.keypedia.com/records/fda_inspections/gilead-sciences-inc/dbdc0e3e-6f75-4d2e-a2df-a091f1eedd2c) — classification: No Action Indicated (NAI), source: FDA, date: January 29, 2025
- [483 - Gilead Sciences, Inc. - 2024-01-22](https://www.keypedia.com/records/483/gilead-sciences-inc/450911dd-b16c-4d24-9f1f-d8db6731ac1f) — source: FDA, date: January 22, 2024
- [FDA Inspection 1227801 - Gilead Sciences, Inc. - 2024-01-22](https://www.keypedia.com/records/fda_inspections/gilead-sciences-inc/1ada62d7-f556-40ea-a042-e913169157c1) — classification: Voluntary Action Indicated (VAI), source: FDA, date: January 22, 2024
- [FDA Inspection 1227801 - Gilead Sciences, Inc. - 2024-01-22](https://www.keypedia.com/records/fda_inspections/gilead-sciences-inc/83ee39e1-a76c-424b-a9e1-f1575491e17e) — classification: Voluntary Action Indicated (VAI), source: FDA, date: January 22, 2024
- [EIR - Gilead Sciences, Inc. - 2020-08-18](https://www.keypedia.com/records/eir/gilead-sciences-inc/ac7782b1-69ff-4699-ab93-7ddafa77096d) — source: FDA, date: August 18, 2020
- [FDA Inspection 1128174 - Gilead Sciences, Inc. - 2020-08-18](https://www.keypedia.com/records/fda_inspections/gilead-sciences-inc/affa7812-ab65-42ac-a157-78c538e9ac4f) — classification: No Action Indicated (NAI), source: FDA, date: August 18, 2020
- [483 - Gilead Sciences, Inc. - 2020-07-22](https://www.keypedia.com/records/483/gilead-sciences-inc/9e0555b0-3c5e-4b85-9607-53ee62563b81) — source: FDA, date: July 22, 2020
- [FDA Inspection 1125580 - Gilead Sciences, Inc. - 2020-07-22](https://www.keypedia.com/records/fda_inspections/gilead-sciences-inc/7f61bbbc-bccb-4fea-97ef-3d2561b789f2) — classification: Voluntary Action Indicated (VAI), source: FDA, date: July 22, 2020
- [EIR - Gilead Sciences, Inc. - 2019-04-04](https://www.keypedia.com/records/eir/gilead-sciences-inc/122c5b07-52e0-4fe8-805d-f16159b2398e) — source: FDA, date: April 4, 2019
- [FDA Inspection 1086848 - Gilead Sciences, Inc. - 2019-04-04](https://www.keypedia.com/records/fda_inspections/gilead-sciences-inc/0e18a779-d1a7-4a36-b8f8-51ef1109afd6) — classification: No Action Indicated (NAI), source: FDA, date: April 4, 2019
- [483 - Gilead Sciences, Inc. - 2018-07-17](https://www.keypedia.com/records/483/gilead-sciences-inc/6e644d94-ebcd-4830-b63d-611baa563e49) — source: FDA, date: July 17, 2018
- [FDA Inspection 1065316 - Gilead Sciences, Inc. - 2018-07-17](https://www.keypedia.com/records/fda_inspections/gilead-sciences-inc/8f4088fc-9cb2-4dc1-ab52-b384dafafd57) — classification: Voluntary Action Indicated (VAI), source: FDA, date: July 17, 2018
- [EIR - Gilead Sciences, Inc. - 2014-07-25](https://www.keypedia.com/records/eir/gilead-sciences-inc/4d8c1bd4-44f6-42a9-9c13-5b7a7fe8c709) — source: FDA, date: July 25, 2014
- [EIR - Gilead Sciences, Inc. - 2014-01-15](https://www.keypedia.com/records/eir/gilead-sciences-inc/c7b9997b-f0fa-4033-9588-5b86b5883afb) — source: FDA, date: January 15, 2014
- [483 - Gilead Sciences, Inc. - 2013-04-26](https://www.keypedia.com/records/483/gilead-sciences-inc/1668a78c-7b58-4b65-bc78-75deefa4d1b1) — source: FDA, date: April 26, 2013

## Related Companies

- [Geneva Laboratories, Inc](https://www.keypedia.com/companies/geneva-laboratories-inc/f06d802f-33ba-4e22-8fba-667d97ec0721)
- [Sterling Pharmaceutical Services LLC](https://www.keypedia.com/companies/sterling-pharmaceutical-services-llc/73705333-126e-43ca-a087-e2ca2717f15d)
- [Eurofins PROXY Laboratories B.V.](https://www.keypedia.com/companies/eurofins-proxy-laboratories-bv/2efa7b51-ca37-4d11-aa86-bb3a7d987ca7)
- [ACTA Laboratories, Inc.](https://www.keypedia.com/companies/acta-laboratories-inc/215a2fac-a2d0-4b2e-b8ca-8c9abe4cbb7d)
- [JNTL Consumer Health (India) Private Limited](https://www.keypedia.com/companies/jntl-consumer-health-india-private-limited/c01240ca-9744-4980-acd1-73e7bd333295)
- [ChemWerth Pharmaceutical Technology (Shanghai) Co., LTD](https://www.keypedia.com/companies/chemwerth-pharmaceutical-technology-shanghai-co-ltd/bdd0edbf-bcaf-451b-ba0a-84c241db8655)
- [Solaris Pharma Corp](https://www.keypedia.com/companies/solaris-pharma-corp/2730f83a-223f-4ef6-95e1-4e3b069342ce)
- [UFAG Laboratorien AG](https://www.keypedia.com/companies/ufag-laboratorien-ag/93342d96-9cf8-4c5f-9248-11d77990b790)
- [Ultragenyx Pharmaceutical Inc.](https://www.keypedia.com/companies/ultragenyx-pharmaceutical-inc/52e0a912-e566-4a1d-89b4-822a2feaf1d0)
- [Sai Life Sciences Limited](https://www.keypedia.com/companies/sai-life-sciences-limited/6a4eee18-c1a6-4bc3-8ba0-014f87b57c2d)

## Related Officers

- [company_representative](https://www.keypedia.com/people/shaun-crofts/699c1377-8871-4679-96b1-3aa3802dbd67)
- [Kristin M. Abaonza](https://www.keypedia.com/people/kristin-m-abaonza/cf909da8-837d-4dfe-9ccc-288b24d7bba3)
- [Jennifer H. Rhyu](https://www.keypedia.com/people/jennifer-h-rhyu/16509dc0-577e-4054-8d78-c488d8154198)
- [Chemist/Investigator - Pharmaceutical Quality](https://www.keypedia.com/people/walden-h-lee/18131eea-d1cb-47c4-af79-bea22d436031)
- [ Assistant Country Director (USFDA India Office Drug Program)](https://www.keypedia.com/people/daniel-j-roberts/1e1836ac-8bca-4236-a267-33ee0456440c)